Results 1 to 7 of 7
Page 1 of 1
PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signalingLiu, Y; Lui, ELH; Friedman, SL; Li, L; Ye, T; Chen, Y; Poon, RT; Wo, J; Kok, TW; Fan, ST2009247
Blockade of chemokine (C-X-C motif) receptor 4 for the treatment of hepatocellular carcinoma metastasis (Poster Presentation)Kok, TW; Yang, Z; Poon, RTP200764
Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinomaLiu, Y; Poon, RTP; Shao, W; Sun, X; Chen, H; Kok, TW; Fan, ST2007162
Blockade of VEGF/VEGFR pathway enhances chemo-sensitivity in hepatocellular carcinoma (Poster Presentation)Yang, Z; Kok, TW; Or, YYY; Ng, NP; Tam, KH; Fan, ST; Poon, RTP2007102
A study of the effect of vascular endothelial growth factor tyrosine kinase inhibitor PTK 787/ZK222584 on liver fibrosis (Abstract)Liu, Y; Poon, RTP; Qian, XM; Li, L; Lau, CPY; Chen, YJ; Kok, TW; Fan, ST200672
Involvement of protein kinase C and E2F-5 in euxanthone-induced neurite differentiation of neuroblastomaHa, WY; Wu, PK; Kok, TW; Leung, KW; Mak, NK; Yue, PYK; Ngai, SM; Tsai, SN; Wong, RNS200662
Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584Liu, Y; Poon, RT; Li, Q; Kok, TW; Lau, C; Fan, ST2005150
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download